LTAS
VRTX icon

Linden Thomas Advisory Services’s Vertex Pharmaceuticals VRTX Stock Holding History

Linden Thomas Advisory Services’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.03M Sell
8,103
-20
-0.2% -$8.86K 0.32% 73
2026
Q1 		$3.63M Sell
8,123
-282
-3% -$131K 0.35% 72
2025
Q4 		$3.81M Sell
8,405
-14
-0.2% -$6.03K 0.39% 62
2025
Q3 		$3.3M Buy
8,419
+258
+3% +$108K 0.33% 76
2025
Q2 		$3.63M Buy
8,161
+428
+6% +$197K 0.4% 66
2025
Q1 		$3.75M Buy
7,733
+292
+4% +$136K 0.49% 41
2024
Q4 		$3M Buy
7,441
+644
+9% +$299K 0.38% 63
2024
Q3 		$3.16M Buy
6,797
+613
+10% +$294K 0.43% 45
2024
Q2 		$2.9M Sell
6,184
-139
-2% -$60.3K 0.45% 43
2024
Q1 		$2.64M Buy
6,323
+323
+5% +$137K 0.42% 42
2023
Q4 		$2.44M Buy
6,000
+541
+10% +$200K 0.46% 42
2023
Q3 		$1.9M Sell
5,459
-7,135
-57% -$2.5M 0.42% 49
2023
Q2 		$4.43M Buy
12,594
+626
+5% +$211K 0.98% 6
2023
Q1 		$3.77M Buy
11,968
+482
+4% +$145K 0.94% 11
2022
Q4 		$3.32M Buy
+11,486
New +$3.5M 0.93% 7

Other funds holding VRTX

Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
DC
Davenport & Co Richmond, Virginia $20.4B AUM 18.11% 1-Year Est. Return
CTB
Country Trust Bank Bloomington, Illinois $5.71B AUM 25.48% 1-Year Est. Return
CNB
Czech National Bank Prague, Czech Republic $18.3B AUM 43.04% 1-Year Est. Return
GIA
Gateway Investment Advisers Cincinnati, Ohio $10.1B AUM 40.26% 1-Year Est. Return
MLL
Moody Lynn & Lieberson Boston, Massachusetts $1.9B AUM 27.82% 1-Year Est. Return
AP
Atwood & Palmer Kansas City, Missouri $1.87B AUM 24.22% 1-Year Est. Return
COPPSERS
Commonwealth of Pennsylvania Public School Employees Retirement System Harrisburg, Pennsylvania $20.6B AUM 37.37% 1-Year Est. Return

Linden Thomas Advisory Services's VRTX Position: Q2 2026 in Review

Linden Thomas Advisory Services reduced its Vertex Pharmaceuticals (VRTX) stake by 0.25% in Q2 2026, selling an estimated $8.86K and leaving 8,103 shares worth $4.03M. The position accounts for 0.32% of the portfolio, ranked #73.

Linden Thomas Advisory Services first reported a position in VRTX in Q4 2022 and has held it in 15 quarters since. The position peaked at $4.43M in Q2 2023. 296 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.

  • Linden Thomas Advisory Services held 8,103 shares of Vertex Pharmaceuticals worth $4.03M as of Q2 2026.
  • Linden Thomas Advisory Services sold 20 Vertex Pharmaceuticals shares in Q2 2026, an estimated $8.86K.
  • Vertex Pharmaceuticals made up 0.32% of Linden Thomas Advisory Services's portfolio in Q2 2026, its #73 holding.
  • Linden Thomas Advisory Services first reported a position in Vertex Pharmaceuticals in Q4 2022 and has held it in 15 quarters since.
  • Linden Thomas Advisory Services's Vertex Pharmaceuticals position peaked at $4.43M in Q2 2023.
  • 296 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.

Based on Linden Thomas Advisory Services's 13F filing for Q2 2026, filed 16 Jul 2026.